Birdwatch Note Rating
2024-06-10 22:19:08 UTC - HELPFUL
Rated by Participant: ABCAEC7584C860170D93DC9A68FA209647A7993726F6821DBE954BD297297994
Participant Details
Original Note:
A two-shot course of Pfizer Inc.’s vaccine may have just 22.5% efficacy against symptomatic infection with the omicron variant, but can thwart severe disease, according to laboratory experiments in South Africa. https://www.bloomberg.com/news/articles/2021-12-11/pfizer-course-has-23-efficacy-vs-omicron-in-s-african-study
All Note Details